93 related articles for article (PubMed ID: 25740466)
1. The TNM system (version 7) is the most accurate staging system for the prediction of loss of life expectancy in differentiated thyroid cancer.
Tanase K; Thies ED; Mäder U; Reiners C; Verburg FA
Clin Endocrinol (Oxf); 2016 Feb; 84(2):284-291. PubMed ID: 25740466
[TBL] [Abstract][Full Text] [Related]
2. The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2018 Jun; 88(6):950-956. PubMed ID: 29573277
[TBL] [Abstract][Full Text] [Related]
3. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
Wong RM; Bresee C; Braunstein GD
Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
[TBL] [Abstract][Full Text] [Related]
4. Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
Verburg FA; Mäder U; Tanase K; Thies ED; Diessl S; Buck AK; Luster M; Reiners C
J Clin Endocrinol Metab; 2013 Jan; 98(1):172-80. PubMed ID: 23150687
[TBL] [Abstract][Full Text] [Related]
5. A comparison of prognostic classification systems for differentiated thyroid carcinoma.
Verburg FA; Mäder U; Kruitwagen CL; Luster M; Reiners C
Clin Endocrinol (Oxf); 2010 Jun; 72(6):830-8. PubMed ID: 19863574
[TBL] [Abstract][Full Text] [Related]
6. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
van Velsen EFS; Peeters RP; Stegenga MT; van Kemenade FJ; van Ginhoven TM; van Balkum M; Verburg FA; Visser WE
J Clin Endocrinol Metab; 2023 May; 108(6):e267-e274. PubMed ID: 36508298
[TBL] [Abstract][Full Text] [Related]
8. Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma.
Kim YN; Kim M; Ahn HS; Kim K; Park SY; Kim HI; Jeon MJ; Kim WG; Kim SW; Kim WB; Chung JH; Shong YK; Kim TY; Kim TH
Oral Oncol; 2019 Feb; 89():8-13. PubMed ID: 30732964
[TBL] [Abstract][Full Text] [Related]
9. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M; Kim YN; Kim WG; Park S; Kwon H; Jeon MJ; Ahn HS; Jung SH; Kim SW; Kim WB; Chung JH; Shong YK; Kim TH; Kim TY
Clin Endocrinol (Oxf); 2017 Mar; 86(3):438-443. PubMed ID: 27731521
[TBL] [Abstract][Full Text] [Related]
10. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.
Mankarios D; Baade P; Youl P; Mortimer RH; Onitilo AA; Russell A; Doi SA
Endocrine; 2014 Jun; 46(2):300-8. PubMed ID: 24174176
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.
Kim TH; Kim YN; Kim HI; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Kim K; Jeong JG; Kim SW; Chung JH
Oral Oncol; 2017 Aug; 71():81-86. PubMed ID: 28688696
[TBL] [Abstract][Full Text] [Related]
12. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
13. Simplifying the TNM system for clinical use in differentiated thyroid cancer.
Onitilo AA; Engel JM; Lundgren CI; Hall P; Thalib L; Doi SA
J Clin Oncol; 2009 Apr; 27(11):1872-8. PubMed ID: 19273697
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of differentiated thyroid carcinoma staging systems in a Spanish population].
Andía Melero VM; Martín de Santa-Olalla Llanes M; Sambo Salas M; Percovich Hualpa JC; Motilla de la Cámara M; Collado Yurrita L
Endocrinol Nutr; 2015 Apr; 62(4):152-60. PubMed ID: 25744071
[TBL] [Abstract][Full Text] [Related]
15. Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with
Park J; Lee S; Park J; Park H; Ki CS; Oh YL; Shin JH; Kim JS; Kim SW; Chung JH; Kim K; Kim TH
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208345
[TBL] [Abstract][Full Text] [Related]
16. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
17. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.
Brierley JD; Panzarella T; Tsang RW; Gospodarowicz MK; O'Sullivan B
Cancer; 1997 Jun; 79(12):2414-23. PubMed ID: 9191532
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
20. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]